Further research has confirmed the neuroprotective role of hippocampal FTO in depression-like behavior through the activation of the CaMKII/CREB signaling pathway, improving hippocampal synaptic plasticity (dendritic remodeling, PSD95, and SYN expression) [55]. Here, DLG4 is linked to depressive symptom measurement.